ZSH‐2208: A novel retinoid with potent anti‐tumour effects on ESCC stem cells via RARγ–TNFAIP3 axis

Documenti analoghi

• Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours
  di: Ling Ni
  Pubblicazione: (2024)
• HBx hijacks the miR‐19a‐3p/BAMBI/TGF‐β1 axis to impair the anti‐tumour activity of CD4 + T cells in diffuse large B‐cell lymphoma
  di: Xuecong Guo, et al.
  Pubblicazione: (2026)
• A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
  di: Xingxing Li, et al.
  Pubblicazione: (2025)
• Evaluation of drug–drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects
  di: Jingcheng Chen, et al.
  Pubblicazione: (2024)
• Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
  di: Di Chen, et al.
  Pubblicazione: (2024)